Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Acquisitions (2022)

Palisade Bio (PALI) has disclosed Acquisitions for 2 consecutive years, with -$3.3 million as the latest value for Q4 2022.

  • On a quarterly basis, Acquisitions changed N/A to -$3.3 million in Q4 2022 year-over-year; TTM through Dec 2022 was -$3.3 million, a N/A change, with the full-year FY2021 number at $3.3 million, changed N/A from a year prior.
  • Acquisitions was -$3.3 million for Q4 2022 at Palisade Bio, down from $54000.0 in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $54000.0 in Q3 2021 to a low of -$3.3 million in Q4 2022.